- Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers.
- Corso G, Robson ME, Sacchini V.
- Ann Surg Oncol. 2022 May 23. doi: 10.1245/s10434-022-11913-6. Epub ahead of print.
- Review, Commentary
Paired Tumor-Germline Testing as a Driver in Better Cancer Care.
BRCA Mutations and the Implications in Transgender Individuals Undergoing Top Surgery: An Operative Dilemma.